APA (7th ed.) Citation

Xu HR, Yang Q, Xiang SY, Zhang PH, Ye Y, Chen Y, . . . Wang Q. (2021). Rosuvastatin Enhances Alveolar Fluid Clearance in Lipopolysaccharide-Induced Acute Lung Injury by Activating the Expression of Sodium Channel and Na,K-ATPase via the PI3K/AKT/Nedd4-2 Pathway. Dove Medical Press.

Chicago Style (17th ed.) Citation

Xu HR, et al. Rosuvastatin Enhances Alveolar Fluid Clearance in Lipopolysaccharide-Induced Acute Lung Injury by Activating the Expression of Sodium Channel and Na,K-ATPase via the PI3K/AKT/Nedd4-2 Pathway. Dove Medical Press, 2021.

MLA (9th ed.) Citation

Xu HR, et al. Rosuvastatin Enhances Alveolar Fluid Clearance in Lipopolysaccharide-Induced Acute Lung Injury by Activating the Expression of Sodium Channel and Na,K-ATPase via the PI3K/AKT/Nedd4-2 Pathway. Dove Medical Press, 2021.